依诺肝素钠治疗非ST段抬高心肌梗死患者的临床分析

Clinical analysis of enoxaparin sodium in the treatment of patients with non ST segment elevation myocardial infarction

目的:探讨依诺肝素钠治疗非ST段抬高心肌梗死(NSTEMI)患者的临床疗效。方法:收治NSTEMI患者100例,平分两组。对照组予以普通肝素钠治疗,观察组予以依诺肝素钠治疗,对两种药物治疗方式的价值对比分析。结果:观察组在改善心肌梗死指标情况,相比较对照组,改善明显,组间对比差异有统计学意义(P<0.05);在不良事件发生率指标上,相比较对照组,明显更低,组间对比差异有统计学意义(P<0.05)。结论:针对NSTEMI患者,将依诺肝素钠于其临床治疗中应用,可有效地改善患者的心肌梗死指标,降低不良事件发生率。

Objective:To investigate the effect of enoxaparin sodium in the treatment of patients with non ST segment elevation myocardial infarction(NSTEMI).Methods:100 patients with NSTEMI were selected,they were divided into the two groups on average,the control group was treated with sodium heparin,the observation group received enoxaparin treatment,we compared and analyzed the value of two kinds of drug treatment.Results:On the index of myocardial infarction in the observation group,the improvement was obvious compared with the control group,and the difference between the groups was statistically significant(P<0.05).On the index of the incidence of adverse events,compared with the control group,the observation group was significantly lower than the control group,and the difference between the groups was statistically significant(P<0.05).Conclusion:For patients with NSTEMI,enoxaparin sodium can be used to improve myocardial infarction in patients and reduce the incidence of adverse events.